Lee Ainslie - Maverick Capital
Holding/activity history for Pacific Biosciences of California (PACB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.82 | |
| 2018 Q3 | 12,173,094 | 0.82 | $5.41 | ||
| 2018 Q2 | 12,173,094 | 0.51 | $3.55 | ||
| 2018 Q1 | 12,173,094 | 0.32 | Add 8.46% | 0.02 | $2.05 |
| 2017 Q4 | 11,223,094 | 0.37 | Add 5.84% | 0.02 | $2.64 |
| 2017 Q3 | 10,603,944 | 0.71 | $5.25 | ||
| 2017 Q2 | 10,603,944 | 0.47 | Add 16.86% | 0.07 | $3.56 |
| 2017 Q1 | 9,073,874 | 0.60 | $5.17 | ||
| 2016 Q4 | 9,073,874 | 0.45 | Reduce 0.24% | 0.00 | $3.80 |
| 2016 Q3 | 9,095,663 | 0.97 | Add 16.30% | 0.14 | $8.96 |
| 2016 Q2 | 7,820,808 | 0.75 | Add 3.43% | 0.02 | $7.03 |
| 2016 Q1 | 7,561,268 | 1.02 | $8.50 | ||
| 2015 Q4 | 7,561,268 | 1.43 | Add 1.41% | 0.02 | $13.13 |
| 2015 Q3 | 7,456,034 | 0.47 | Add 5.59% | 0.02 | $3.66 |
| 2015 Q2 | 7,061,034 | 0.62 | $5.76 | ||
| 2015 Q1 | 7,061,034 | 0.66 | Add 9.31% | 0.06 | $5.84 |
| 2014 Q4 | 6,459,784 | 0.79 | $7.84 | ||
| 2014 Q3 | 6,459,784 | 0.48 | $4.91 | ||
| 2014 Q2 | 6,459,784 | 0.63 | $6.18 | ||
| 2014 Q1 | 6,459,784 | 0.49 | $5.35 |